propecia x finasterida

Information is Power!

Experimental Leukemia Drug, Graspa, May Help Treat Solid Cancer Tumors As Well

February 16, 2010 Pat Killingsworth No Comments

Pat found this article today on Philadelphia Business Journal’s Website:

Erytech Pharma entered into a collaborative research agreement Monday with the M.D. Anderson Center.

Under the partnership, Erytech, a specialty pharmaceutical company with offices in France and Philadelphia, and M.D. Anderson of Houston, will work together to study the potential use of Graspa — Erytech’s flagship new drug candidate — in treating patients with solid tumors.

Graspa is an experimental therapy that consists of red blood cell-encapsulated L-asparaginase, an enyzme used to treat leukemia by damaging cancer cells. By encapsulating the enzyme inside red blood cells, the company is seeking to make Graspa safer and have a broader range of clinical uses as compared to existing forms of L-asparaginase.

Dr. John Weinstein, chair of the department of bioinformatics and computational biology at M.D. Anderson will serve as principal investigator for the project.

Dr. Yann Godfrin, Erytech Pharma’s co-founder and CEO, said the collaboration with M.D. Anderson “provides us the opportunity to develop a clinically-compatible biomarker assay and to rationally prescribe Graspa to patients who are most likely to respond.”

Pat and I learn about so many promising cancer treatment advances each and everyday. I just wish they could finish testing and get to market faster! Pattie

Be Sociable, Share!

Erytech, Graspa, L-asparaginase, leukemia, M.D. Anderson Cancer Center Blood, Solid Tumor, Therapies

Leave a Reply